News

If you are a member of the media and have questions about Bayer in Canada, please contact Marija Mandic, Director of Communications, at marija.mandic@bayer.com, or 905-282-5376.

 

May 5, 2015
Forever Young: Bayer named Top Employer for Young People more
April 22, 2015
Keeping it Green more
April 20, 2015
Bayer HealthCare's Grants4Apps® Accelerator invites Canadian health tech startups to submit their innovative healthcare projects more
March 9, 2015
Bayer introduces Xofigo, a novel treatment for prostate cancer, now publicly funded for patients in Ontario more
February 5, 2015
What to do on Valentine’s Day this year: Break up more
January 23, 2015
Bayer HealthCare Announces Baycox® 5% (toltrazuril) Oral Suspension Approved for Calves in Canada more
December 1, 2014
Bayer Receives Health Canada Approval for Eylea® for Two Additional Indications more
November 13, 2014
Bayer CropScience Unveils State-of-the-Art Packaging Facility more
November 4, 2014
Eight is Great! Bayer named one of Canada’s Top 100 Employers for the eighth consecutive year more
October 22, 2014
ASPIRIN® 81mg for Emergency Use during Heart Attacks: Approved in Canada more
October 20, 2014
Mike Weir Takes a Swing for Arthritis: Golf icon and ALEVE® spokesperson encourages Canadians to break free from their pain more
October 1, 2014
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for USD 14.2 billion more
July 15, 2014
Bayer’s New CONTOUR® NEXT LINK Blood Glucose Meter Now Available in Canada more
July 7, 2014
Nexavar® (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer more
June 17, 2014
Bayer introduces JAYDESS®, a simple and safe alternative to the ‘Pill’ more
May 12, 2014
Bayer’s Grants4Apps Initiative Looking for Canada’s Most Innovative Digital Healthcare Startups more
May 2, 2014
Young and Employable: Bayer Among the Best Places to Work more
April 28, 2014
Positive Results from Phase III DECISION Study of Sorafenib in RAI-Refractory Differentiated Thyroid Cancer Published in... more
April 24, 2014
Quebecers suffering from wet Age-Related Macular Degeneration first with government coverage more
April 24, 2014
Québec First Province to List Adempas® for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) more



You are now leaving www.bayer.ca.